Spironolactone for Atrial Fibrillation Recurrence Reduction after Successful Electrical Cardioversion

Activity: Talk or presentation types › Poster presentation

Description

Pleiotropic effects of non-antiarrhythmic medications have gained increased attention. Indirect antiarrhythmic action of mineralocorticoid receptor anatagonists could help attenuate atrial fibrillation (AF) recurrence after sinus rhythm restoration. Aim of this study was to evaluate the effect of spironolactone on AF recurrence prevention after electrical cardioversion (ECV).. Observational study enrolled patients admitted for elective ECV in whom sinus rhythm was successfully restored. ECV procedure was performed according to protocol accepted in the hospital. Informed consent was signed, confirming participation in the study, and baseline demographic and clinical data were acquired based on available medical documentation. Afterwards, 1-, 3-, 6-, 9- and 12-month follow-up was conducted. Data of sinus rhythm maintenance within 12 months was analyzed regarding medication intake until the point of arrhythmia recurrence. Statistical analysis was performed using IBM SPSS Statistics software. Significance level was defined for P
Period29 Mar 2023
Event titleRSU International Research Conference 2023: Knowledge for Use in Practice
Event typeConference
OrganiserRīga Stradiņš University
LocationRiga, LatviaShow on map
Degree of RecognitionInternational

Related content